ANDA 72409, held by Chase Labs Nj. Nifedipine.
As of Nov 16, 2026, ANDA 72409 (Nifedipine), held by Chase Labs Nj, was first approved by FDA on Jul 10, 1989, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 10, 1989 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Nifedipine10MG ยท capsule;oral | Nifedipine | Discontinued |
| Aug 6, 1992 | Supplement 10Labeling | Approved | None posted |
| Apr 16, 1992 | Supplement 7Labeling | Approved | None posted |
| Sep 12, 1991 | Supplement 5Labeling | Approved | None posted |
| Jul 10, 1989 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters